Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp
Actinic keratoses (AKs) are common lesions on chronically sun damaged skin, which are morphologically characterized by lower third to full thickness atypia of epidermal keratinocytes. These lesions carry a risk of progression towards invasive squamous cell carcinoma (SCC); therefore, treatment of vi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/4/92 |
id |
doaj-eb4f262500274a3092fe4f2d3ca1b4bf |
---|---|
record_format |
Article |
spelling |
doaj-eb4f262500274a3092fe4f2d3ca1b4bf2020-11-25T02:31:28ZengMDPI AGMedicina1010-660X2019-04-015549210.3390/medicina55040092medicina55040092Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and ScalpAlise Balcere0Māra Rone Kupfere1Ingrīda Čēma2Angelika Krūmiņa3Department of Infectiology and Dermatology, Riga Stradiņš University, LV-1006 Riga, LatviaDepartment of Infectiology and Dermatology, Riga Stradiņš University, LV-1006 Riga, LatviaDepartment of Oral Medicine, Riga Stradiņš University, LV-1007 Riga, LatviaDepartment of Infectiology and Dermatology, Riga Stradiņš University, LV-1006 Riga, LatviaActinic keratoses (AKs) are common lesions on chronically sun damaged skin, which are morphologically characterized by lower third to full thickness atypia of epidermal keratinocytes. These lesions carry a risk of progression towards invasive squamous cell carcinoma (SCC); therefore, treatment of visible lesions and the field in case of field cancerization is recommended. Treatment of AK includes the destruction of atypical keratinocytes that clinically presents with various degrees of erythema, scaling, crusting, erosion, and other visible and subjective symptoms. Such inflammatory reactions may have an impact on the patient’s social life and have shown to decrease compliance and adherence to therapy. Additionally, as various topical treatments have been proven to be effective in treating AK, tolerability of local site reactions (LSRs) might drive the decision for appropriate treatment in an individual scenario. Therefore, we aimed to review prevalence of severe LSRs among various topical treatments for AK. In addition, we summarized discontinuation rates due to LSRs and possible therapy-unrelated risk factors for the development of LSRs with increased severity.https://www.mdpi.com/1010-660X/55/4/92actinic keratosistopical therapysevere local site reactionsrisk factorsreview |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alise Balcere Māra Rone Kupfere Ingrīda Čēma Angelika Krūmiņa |
spellingShingle |
Alise Balcere Māra Rone Kupfere Ingrīda Čēma Angelika Krūmiņa Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp Medicina actinic keratosis topical therapy severe local site reactions risk factors review |
author_facet |
Alise Balcere Māra Rone Kupfere Ingrīda Čēma Angelika Krūmiņa |
author_sort |
Alise Balcere |
title |
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp |
title_short |
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp |
title_full |
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp |
title_fullStr |
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp |
title_full_unstemmed |
Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp |
title_sort |
prevalence, discontinuation rate, and risk factors for severe local site reactions with topical field treatment options for actinic keratosis of the face and scalp |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X |
publishDate |
2019-04-01 |
description |
Actinic keratoses (AKs) are common lesions on chronically sun damaged skin, which are morphologically characterized by lower third to full thickness atypia of epidermal keratinocytes. These lesions carry a risk of progression towards invasive squamous cell carcinoma (SCC); therefore, treatment of visible lesions and the field in case of field cancerization is recommended. Treatment of AK includes the destruction of atypical keratinocytes that clinically presents with various degrees of erythema, scaling, crusting, erosion, and other visible and subjective symptoms. Such inflammatory reactions may have an impact on the patient’s social life and have shown to decrease compliance and adherence to therapy. Additionally, as various topical treatments have been proven to be effective in treating AK, tolerability of local site reactions (LSRs) might drive the decision for appropriate treatment in an individual scenario. Therefore, we aimed to review prevalence of severe LSRs among various topical treatments for AK. In addition, we summarized discontinuation rates due to LSRs and possible therapy-unrelated risk factors for the development of LSRs with increased severity. |
topic |
actinic keratosis topical therapy severe local site reactions risk factors review |
url |
https://www.mdpi.com/1010-660X/55/4/92 |
work_keys_str_mv |
AT alisebalcere prevalencediscontinuationrateandriskfactorsforseverelocalsitereactionswithtopicalfieldtreatmentoptionsforactinickeratosisofthefaceandscalp AT mararonekupfere prevalencediscontinuationrateandriskfactorsforseverelocalsitereactionswithtopicalfieldtreatmentoptionsforactinickeratosisofthefaceandscalp AT ingridacema prevalencediscontinuationrateandriskfactorsforseverelocalsitereactionswithtopicalfieldtreatmentoptionsforactinickeratosisofthefaceandscalp AT angelikakrumina prevalencediscontinuationrateandriskfactorsforseverelocalsitereactionswithtopicalfieldtreatmentoptionsforactinickeratosisofthefaceandscalp |
_version_ |
1724824380289056768 |